HOME >> BIOLOGY >> NEWS
Breast self examination increases women's concerns but has no effect on mortality

We are releasing this story before embargo because (1) the embargo has already been broken and (2) it is a sensitive subject that needs to be handled with care to avoid misunderstanding among women.

Hamburg, Germany: Breast self-examination (BSE) should not be seen as a cheaper alternative to mammography, and people who still advocate it as an effective way of reducing breast cancer mortality are doing women a disservice, a scientist will say at the 4th European Breast Cancer Conference next week (Tuesday 16 March). Professor Lars Holmberg, from the Regional Oncologic Centre, Uppsala, Sweden, will explain why BSE should not be promoted as something that can decrease mortality from breast cancer.

Professor Holmberg will comment on a study to be presented at the conference by Professor Vladimir Semiglazov, who conducted and analysed a randomised controlled trial of BSE in nearly 100,000 Russian women between 1985 and 2003. The women had been taught how to examine their breasts correctly, but even so there was no reduction in deaths from breast cancer in the BSE group. And not only did self-examination not affect mortality, it also meant that more women in the BSE group consulted doctors for benign breast lesions than those in the control group.

"Breast self-examination has been widely advocated in the belief that it is beneficial", says Professor Holmberg. "In fact we now know that it can be positively harmful. The women in the BSE group consulted more frequently for relatively harmless conditions, thus having more surgical biopsies, not to mention increased anxiety. While women should be aware of changes in their breasts, just as they should take note of any other unusual signs elsewhere in the body, it is worrying that BSE is still being touted as an alternative to mammographic screening."

"Many people are guilty of continuing to promote this practice", he says, "and I can only assume that it is through
'"/>

Contact: Margaret Willson
m.willson@mwcommunications.org.uk
44-0-1536-772181
Federation of European Cancer Societies
10-Mar-2004


Page: 1 2

Related biology news :

1. Breast cancer patients failed by treatment with taxol and taxotere respond to abraxane
2. Breastfeeding decreases infant mortality
3. Breast cancer study suggests role for tissue in carcinogenesis
4. Breast cancer follow-ups no longer guess-work thanks to new physics research
5. Final media advisory for the 4th European Breast Cancer Conference (EBCC-4)
6. The 4th European Breast Cancer Conference (EBCC4)
7. Breast cancer susceptibility genes play role in DNA repair
8. Breast cancer can be reversed in laboratory mice, scientists report
9. NIH funds Breast Cancer and the Environmental Research Center at Fox Chase Cancer Center
10. Breast fluid a better option for detecting cancer
11. Breastfeeding may compensate for harmful effects of smoking during pregnancy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2020)... (PRWEB) , ... February 06, 2020 , ... ... to facilitate access to unique lab-made bioresearch materials, today announced an agreement with ... and plant-based meat and seafood a reality. Under the partnership, terrestrial meat and ...
(Date:2/5/2020)... ... February 05, 2020 , ... LabKey has ... efficiency and insight to sample processing within laboratories. , Built with input ... research in various fields, LabKey Sample Manager has been designed with an intuitive ...
(Date:1/30/2020)... (PRWEB) , ... January 30, 2020 , ... Accelera ... an eye on the Canadian market, is pleased to announce that the company has ... growth since the company launched in 2017. , “We are so thrilled to ...
Breaking Biology News(10 mins):
(Date:1/24/2020)... Calif. (PRWEB) , ... January 24, 2020 , ... ... launch of their RedySmart™ mass flow meters and controllers ideal for ... as an ideal upgrade to antiquated rotameters. These thermal instruments employ high-precision MEMS ...
(Date:1/22/2020)... FARMINGTON, Conn. (PRWEB) , ... January 21, 2020 , ... ... Cell (CTC) liquid biopsy from a simple blood draw, today announced the sale of ... UConn Health. The Rare Scope will be used in clinical cancer research. , “The ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... helps couples and individuals grow their family, has announced that five of their ... Castle Connolly. Since 1991, the renowned publishing company Castle Connolly has ...
(Date:1/7/2020)... ... 2020 , ... ABCT , the Accelerator for Biosciences ... participate in the annual program. Twelve ventures will participate in the 6.5-month-long program ... All startups will receive an entrepreneur coach, access to active business professionals and ...
Breaking Biology Technology:
Cached News: